Insider Transactions in Q1 2022 at Idexx Laboratories Inc (IDXX)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 04
2022
|
Jonathan Jay Mazelsky President and CEO |
SELL
Bona fide gift
|
Direct |
500
-0.98%
|
-
|
|
Feb 23
2022
|
Giovani Twigge Senior Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
2,599
+6.1%
|
$558,785
$215.19 P/Share
|
|
Feb 18
2022
|
Jonathan W Ayers Director |
BUY
Exercise of conversion of derivative security
|
Direct |
706
+0.11%
|
$99,546
$141.6 P/Share
|
|
Feb 18
2022
|
Kathy V Turner Senior Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
2,180
+14.28%
|
$226,720
$104.73 P/Share
|
|
Feb 17
2022
|
Sharon E. Underberg EVP, GC & Corporate Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
483
+13.92%
|
$99,498
$206.94 P/Share
|
|
Feb 16
2022
|
Brian P Mckeon EVP, CFO and Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
706
+2.45%
|
$99,546
$141.6 P/Share
|
|
Feb 15
2022
|
Jonathan W Ayers Director |
SELL
Open market or private sale
|
Direct |
250
-0.04%
|
$127,250
$509.7 P/Share
|
|
Feb 14
2022
|
Nimrata Hunt Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
204
-2.06%
|
$103,020
$505.53 P/Share
|
|
Feb 14
2022
|
Nimrata Hunt Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
675
+1.38%
|
-
|
|
Feb 14
2022
|
Michael Lane Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
1
-0.02%
|
$505
$505.53 P/Share
|
|
Feb 14
2022
|
Michael Lane Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
922
+4.2%
|
-
|
|
Feb 14
2022
|
Jonathan Jay Mazelsky President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,423
-2.71%
|
$718,615
$505.53 P/Share
|
|
Feb 14
2022
|
Jonathan Jay Mazelsky President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,063
+1.18%
|
-
|
|
Feb 14
2022
|
Brian P Mckeon EVP, CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
964
-3.39%
|
$486,820
$505.53 P/Share
|
|
Feb 14
2022
|
Brian P Mckeon EVP, CFO and Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,085
+1.49%
|
-
|
|
Feb 14
2022
|
James F Polewaczyk Executive Vice President |
BUY
Payment of exercise price or tax liability
|
Direct |
235
+1.51%
|
$118,675
$505.53 P/Share
|
|
Feb 14
2022
|
James F Polewaczyk Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
781
+1.01%
|
-
|
|
Feb 14
2022
|
Kathy V Turner Senior Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
295
-5.9%
|
$148,975
$505.53 P/Share
|
|
Feb 14
2022
|
Kathy V Turner Senior Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
851
+3.52%
|
-
|
|
Feb 14
2022
|
Giovani Twigge Senior Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
252
-1.4%
|
$127,260
$505.53 P/Share
|
|
Feb 14
2022
|
Giovani Twigge Senior Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
835
+0.94%
|
-
|
|
Feb 14
2022
|
Sharon E. Underberg EVP, GC & Corporate Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
253
-9.18%
|
$127,765
$505.53 P/Share
|
|
Feb 14
2022
|
Sharon E. Underberg EVP, GC & Corporate Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
838
+9.72%
|
-
|
|
Feb 11
2022
|
Jonathan W Ayers Director |
SELL
Bona fide gift
|
Direct |
8,000
-1.25%
|
-
|
|
Feb 07
2022
|
M Anne Szostak Director |
BUY
Bona fide gift
|
Indirect |
660
+50.0%
|
-
|
|
Feb 07
2022
|
M Anne Szostak Director |
SELL
Bona fide gift
|
Indirect |
660
-9.15%
|
-
|
|
Jan 28
2022
|
Asha Collins Director |
BUY
Grant, award, or other acquisition
|
Direct |
41
+18.72%
|
$20,049
$489.05 P/Share
|
|
Jan 28
2022
|
Stuart Essig Director |
BUY
Grant, award, or other acquisition
|
Direct |
49
+4.09%
|
$23,961
$489.05 P/Share
|
|
Jan 28
2022
|
Daniel M Junius Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.44%
|
$6,357
$489.05 P/Share
|